PP405 not checked

Pelage Pharmaceuticals, Inc.

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 2 trial completes
Trials
2 active
3 in total
Targets
—
None known yet

What this is

How it works
How it works isn't classified yet
Tested for
Androgenetic Alopecia (2 trials)
Main trialPhase 2/3
“The study is designed to validate efficacy and long term safety of PP405.”In the company’s words, NCT07819435 on ClinicalTrials.gov

Other drugs for Androgenetic Alopecia

All 36 drugs for Androgenetic Alopecia

Coming up2

Changes1

Last 90 days

Trials3

TrialPhaseCompletesWhat it tests
Phase 2/3Recruiting Dec 2027 Phase 2/3 Efficacy and Safety of PP405 in Adult Males
Phase 2Recruiting Sep 2027 Phase 2 Efficacy and Safety of PP405 in Adult Females With Androgenetic Alopecia
Phase 2Completed 16 Jul 2025 Safety, Pharmacokinetics and Efficacy of PP405 in Adults With AGA
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026

Follow PP405

Following is part of Solo: you see every change to PP405 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in